Association between antipsychotics and cardiovascular adverse events
Prijzen vanaf
VERGELIJK ALLE AANBIEDERS
(1)
Bol
There is controversy about the association between cardiovascular adverse events and the use of antipsychotic agents in schizophrenic patients. Cardiovascular diseases are the leading cause of death worldwide and high mortality rates have been observed in patients with schizophrenia. The aim of this study is to determine whether there is an association between the risk of cardiovascular adverse events and the use of antipsychotic agents in schizophrenic patients.
Lees meer
49,90
Uitgelicht
|
49,90 |
Naar shop
|
Beschrijving
Bol
There is controversy about the association between cardiovascular adverse events and the use of antipsychotic agents in schizophrenic patients. Cardiovascular diseases are the leading cause of death worldwide and high mortality rates have been observed in patients with schizophrenia. The aim of this study is to determine whether there is an association between the risk of cardiovascular adverse events and the use of antipsychotic agents in schizophrenic patients.
Vergelijk aanbieders (1)
Shop
Prijs
Verzendkosten
Totale prijs
Beschrijving
(1)
There is controversy about the association between cardiovascular adverse events and the use of antipsychotic agents in schizophrenic patients. Cardiovascular diseases are the leading cause of death worldwide and high mortality rates have been observed in patients with schizophrenia. The aim of this study is to determine whether there is an association between the risk of cardiovascular adverse events and the use of antipsychotic agents in schizophrenic patients.
Productspecificaties
| EAN |
|
|---|---|
| Maat |
|
Prijshistorie
Prijzen voor het laatst bijgewerkt op:
Gerelateerde producten
Uitgelichte Keuze
49,90
